Recursion Pharmaceuticals combines artificial intelligence, automation, and biotechnology research across multiple ...

The current calendar covers exhibitions dedicated to Brâncuşi’s legacy, highlights from the collections of local museums, and ...

On June 24, 2026, Microsoft’s Digital Crimes Unit (DCU) facilitated the takedown, suspension, and blocking of domains that ...

In Barrie's Peter Pan, Wendy sewed Peter's mischievous shadow back on his feet. Wendy saw what was incomplete and chose to ...

Dezeen School Shows: a native wetland ecosystem for a flood-risked neighbourhood in New Orleans is among the projects from ...

How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...

Recursion's co-founder and long-serving chief executive, Chris Gibson, has switched to the role of company chair, and will be succeeded in the CEO role by R&D and commercial head Najat Khan. The ...

For more than three decades, researchers studying genomes have relied on foundational resources such as Repbase and, more ...

In the AI value chain, application-layer leaders like Palantir and ServiceNow may win long term as chip/cloud margins ...

This week’s cybersecurity recap covers Firefox and Chrome bugs, EDR-killer tools, a TV botnet, an OpenBSD flaw, Android ...

Forbes contributors publish independent expert analyses and insights. Dr. Lance B. Eliot is a world-renowned AI scientist and consultant. This voice experience is generated by AI. Learn more. This ...

Abstract: This paper studies the control-oriented recursive identification of finite impulse response systems with binary-valued observations. Inspired by the Maximum Likelihood method, a novel ...